Enable your JavaScript to use Numstock


Numstock » ABUS

ABUS Stock Analysis

The latest metrics for Arbutus Biopharma Corporation

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -0.83
Price / Book Value Ratio < 1.5 2.56
Price / Sales Ratio < 2.0 13.7
PEG Ratio < 1.0 0.0
EV / EBITDA Ratio < 8.0 -1.88
Price / FCF Ratio Last Year < 15.0 -1.14
Price / FCF Ratio Last Quarter < 15.0 -4.52
Price / TBV Ratio Last Year < 0.7 10.45
Price / TBV Ratio Last Quarter < 0.7 -1.66
Price / NCAV Ratio Last Year < 0.7 0.8
Price / NCAV Ratio Last Quarter < 0.7 1.39

Efficiency

Metric Target Value
ROE Last Year > 25.0% -55.19
ROE Last Quarter > 25.0% 921
ROA Last Year > 15.0% -25.04
ROA Last Quarter > 15.0% -70.35
ROTA Last Year > 20.0% -59.83
ROTA Last Quarter > 20.0% -15.71
ROIC Last Year > 20.0% -33.95
ROIC Last Quarter > 20.0% 225.9
ROCE Last Year > 20.0% -32.39
ROCE Last Quarter > 20.0% -17.38
Inventory Turnover Last Year > 4.0 0.0
Inventory Turnover Last Quarter > 4.0 0.0
Pre-tax Margin Last Year > 20.0% -1215
Pre-tax Margin Last Quarter > 20.0% -3412
Accounts Payable Turnover Last Year > 3.0 18.15
Accounts Payable Turnover Last Quarter > 3.0 12.66
Accounts Receivable Turnover Last Year > 5.0 31.83
Accounts Receivable Turnover Last Quarter > 5.0 9.74

Health

Metric Target Value
Current Ratio Last Year > 1.5 11.5
Current Ratio Last Quarter > 1.5 8.39
Quick Ratio Last Year > 1.5 11.5
Quick Ratio Last Quarter > 1.5 8.39
Flow Ratio Last Year < 1.25 8.21
Flow Ratio Last Quarter < 1.25 0.38
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.0
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 0.0
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.0
Interest Coverage Ratio Ratio Last Year > 8.0 310.5
Interest Coverage Ratio Last Quarter > 8.0 16.75
FCF / Sales Ratio Last Year > 8.0% -1161
FCF / Sales Ratio Last Quarter > 8.0% -775.1

Growth

Metric Target Value
Earnings Yield > 12% -120.9
Ebit Yield Last Year > 12% -93.73
Ebit Yield Last Quarter > 12% -66.53
FCF Yield Last Year > 10% -82.01
FCF Yield Last Quarter > 10% -28.2
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.69
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.23

Dividends

Metric Target Value
Dividend Yield > 2.0% 11.99
FCF / Dividends Paid Ratio Last Year > 2.5 6.84
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 9.76
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 10.25

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -5.1
Altman Z-score Last Quarter ≥ 3.5 -10.46